Past proteomic studies have utilized both targeted IPs and whole-cell analysis to map the proteome of cells expressing various toxic ALS-linked FUS mutations (i.e., P525L, R495X) (54, 67, 86). This evidence concerns the gene FUS and amyotrophic lateral sclerosis.